260 related articles for article (PubMed ID: 21466534)
1. German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD.
Marks C; Stadler M; Häusermann P; Wolff D; Buchholz S; Stary G; Lee S; Lawitschka A; Bertz H
Br J Dermatol; 2011 Jul; 165(1):18-29. PubMed ID: 21466534
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
[TBL] [Abstract][Full Text] [Related]
3. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.
Wolff D; Gerbitz A; Ayuk F; Kiani A; Hildebrandt GC; Vogelsang GB; Elad S; Lawitschka A; Socie G; Pavletic SZ; Holler E; Greinix H
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1611-28. PubMed ID: 20601036
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.
Greinix HT; Loddenkemper C; Pavletic SZ; Holler E; Socié G; Lawitschka A; Halter J; Wolff D
Biol Blood Marrow Transplant; 2011 Feb; 17(2):167-75. PubMed ID: 20691801
[TBL] [Abstract][Full Text] [Related]
5. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
6. UV treatment of chronic skin graft-versus-host disease--focus on UVA1 and extracorporeal photopheresis.
Greinix HT; Tanew A
Curr Probl Dermatol; 2012; 43():116-31. PubMed ID: 22377925
[TBL] [Abstract][Full Text] [Related]
7. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.
Wolff D; Schleuning M; von Harsdorf S; Bacher U; Gerbitz A; Stadler M; Ayuk F; Kiani A; Schwerdtfeger R; Vogelsang GB; Kobbe G; Gramatzki M; Lawitschka A; Mohty M; Pavletic SZ; Greinix H; Holler E
Biol Blood Marrow Transplant; 2011 Jan; 17(1):1-17. PubMed ID: 20685255
[TBL] [Abstract][Full Text] [Related]
8. Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD.
Blecha C; Wolff D; Holler B; Holler E; Weber D; Vogt R; Helbig H; Dietrich-Ntoukas T
Ann Hematol; 2016 Feb; 95(3):493-9. PubMed ID: 26659079
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of rituximab in chronic graft-versus-host disease.
Bates JS; Engemann AM; Hammond JM
Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
[TBL] [Abstract][Full Text] [Related]
11. Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers.
Wolff D; Ayuk F; Elmaagacli A; Bertz H; Lawitschka A; Schleuning M; Meyer RG; Gerbitz A; Hilgendorf I; Hildebrandt GC; Edinger M; Klein S; Halter J; Mousset S; Holler E; Greinix HT
Biol Blood Marrow Transplant; 2013 May; 19(5):767-76. PubMed ID: 23376495
[TBL] [Abstract][Full Text] [Related]
12. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.
Hillen U; Häusermann P; Massi D; Janin A; Wolff D; Lawitschka A; Greinix H; Meyer R; Ziemer M
J Eur Acad Dermatol Venereol; 2015 May; 29(5):948-54. PubMed ID: 25265987
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
14. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients.
Noce CW; Gomes A; Copello A; Barbosa RD; Sant'anna S; Moreira MC; Correa ME; Maiolino A; Torres SR
Gen Dent; 2011; 59(6):458-62; quiz 463-4. PubMed ID: 22313917
[TBL] [Abstract][Full Text] [Related]
15. The effect of budesonide mouthwash on oral chronic graft versus host disease.
Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
[TBL] [Abstract][Full Text] [Related]
16. Chronic graft-versus-host disease presenting as eosinophilic fasciitis: therapeutic challenges and an additional case.
Ganta CC; Chatterjee S; Pohlman B; Hojjati M
J Clin Rheumatol; 2015 Mar; 21(2):86-94. PubMed ID: 25710860
[TBL] [Abstract][Full Text] [Related]
17. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
18. Chronic graft versus host disease of oral mucosa: review of available therapies.
Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
[TBL] [Abstract][Full Text] [Related]
19. Chronic graft-versus-host disease: is there an alternative to the conventional treatment?
Gaziev D; Galimberti M; Lucarelli G; Polchi P
Bone Marrow Transplant; 2000 Apr; 25(7):689-96. PubMed ID: 10745252
[TBL] [Abstract][Full Text] [Related]
20. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
